107 related articles for article (PubMed ID: 8532700)
1. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease.
Krishna M; Woda B; Savas L; Baker S; Banner B
Mod Pathol; 1995 Aug; 8(6):654-7. PubMed ID: 8532700
[TBL] [Abstract][Full Text] [Related]
2. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
Autschbach F; Giese T; Gassler N; Sido B; Heuschen G; Heuschen U; Zuna I; Schulz P; Weckauf H; Berger I; Otto HF; Meuer SC
Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
[TBL] [Abstract][Full Text] [Related]
4. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis.
Arai N; Mitomi H; Ohtani Y; Igarashi M; Kakita A; Okayasu I
Mod Pathol; 1999 Jun; 12(6):604-11. PubMed ID: 10392637
[TBL] [Abstract][Full Text] [Related]
5. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F
J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600
[TBL] [Abstract][Full Text] [Related]
6. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
8. Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.
ter Beek WP; Muller ES; Van Hogezand RA; Biemond I; Lamers CB
J Clin Pathol; 2004 Oct; 57(10):1047-51. PubMed ID: 15452158
[TBL] [Abstract][Full Text] [Related]
9. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
11. Biopsy histamine in ulcerative colitis and Crohn's disease.
Baenkler HW; Lux G; Günthner R; Kohlhäufl M; Matek W
Hepatogastroenterology; 1987 Dec; 34(6):289-90. PubMed ID: 3428863
[TBL] [Abstract][Full Text] [Related]
12. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis].
Maruyama K; Saigusa N; Baba S; Kino I
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():145-8. PubMed ID: 7611778
[TBL] [Abstract][Full Text] [Related]
14. Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease.
Mitomi H; Ohkura Y; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Fukui N; Kanazawa H; Kishimoto I; Saigenji K
Pathol Res Pract; 2007; 203(10):717-23. PubMed ID: 17869012
[TBL] [Abstract][Full Text] [Related]
15. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21 expression in rectal mucosa and neoplastic development.
Mitsuhashi J; Mikami T; Saigenji K; Okayasu I
Pathol Int; 2005 Mar; 55(3):113-21. PubMed ID: 15743319
[TBL] [Abstract][Full Text] [Related]
16. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
17. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
18. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M
Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]